Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Exousia Bio (LMMY) Other Non Operating Income (2024 - 2025)

Lamy (LMMY) has disclosed Other Non Operating Income for 2 consecutive years, with $217922.0 as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income rose 150.17% to $217922.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $303632.0 through Nov 2025, up 245.13% year-over-year, with the annual reading at $86739.0 for FY2025, 19794.27% up from the prior year.
  • Other Non Operating Income hit $217922.0 in Q4 2025 for Lamy, up from $85710.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $217922.0 in Q4 2025 to a low of $431.0 in Q3 2024.